<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385292</url>
  </required_header>
  <id_info>
    <org_study_id>OCUN-003</org_study_id>
    <nct_id>NCT02385292</nct_id>
  </id_info>
  <brief_title>Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation</brief_title>
  <official_title>Randomized, Controlled, Crossover, Multicenter Trial Comparing Quality of Tears Produced by Nasal Neurostimulation Versus Sham for Dry Eye</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oculeve, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oculeve, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are:

        -  To compare the change in levels of tear proteins and inflammatory mediators pre and post
           administration between the intranasal and extranasal applications

        -  To compare the goblet cell count following application between the intranasal and
           extranasal applications

        -  To compare fluorescein tear clearance with the application of the device intranasally
           and extranasally applications
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, subjects will participate for three study days during up to a 44 day period,
      consisting of a screening examination to determine eligibility on one day and study
      applications on two different days. There are two applications, intranasal and extranasal.
      Subjects will receive both applications, in random sequence, one at each of the two
      application days (Visit 2 and Visit 3). The two applications consist of:

        -  Active intranasal device application

        -  Active extranasal device application
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fluorescein tear clearance with application</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Level of tear proteins pre and post administration</measure>
    <time_frame>1 day</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Level of inflammatory mediators pre and post administration</measure>
    <time_frame>1 day</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Goblet cell count following application</measure>
    <time_frame>1 day</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Dry Eye Syndromes</condition>
  <arm_group>
    <arm_group_label>Intranasal application of the device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intranasal application of the Oculeve Intranasal Lacrimal Neurostimulator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extranasal application of the device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extranasal application of the Oculeve Intranasal Lacrimal Neurostimulator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oculeve Intranasal Lacrimal Neurostimulator</intervention_name>
    <description>The Oculeve Intranasal Lacrimal Neurostimulator applies a small electrical current to gently activate the body's natural tear production system.</description>
    <arm_group_label>Intranasal application of the device</arm_group_label>
    <arm_group_label>Extranasal application of the device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral dry eyes

          -  Capable of providing written informed consent

        Exclusion Criteria:

          -  Chronic or recurring epistaxis (nosebleeds)

          -  Blood coagulation disorder

          -  Uncontrolled or poorly controlled diabetes

          -  Heart or pulmonary disease

          -  Females who are pregnant, planning a pregnancy or nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Lewis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Grutzmacher, Lewis &amp; Sierra</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grutzmacher, Lewis &amp; Sierra</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine, Department of Ophthalmology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2015</study_first_submitted>
  <study_first_submitted_qc>March 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>April 7, 2017</last_update_submitted>
  <last_update_submitted_qc>April 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

